ArticleFrontiers in oncology2026
Granulomatous cutaneous T-cell lymphoma in a patient with atage IVB of mycosis fungoides: a case report and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Granulomatous mycosis fungoides (GMF) represents a distinct pathological variant of mycosis fungoides (MF), mycosis fungoides, originating from memory helper T cells, is the most prevalent form of primary cutaneous T-cell lymphoma. It is characterized as an inactive CD4+ non-Hodgkin lymphoma, where in some patients lesions gradually evolve into plaques or tumors over several years. Presentation: The patient presented with multiple masses on his trunk and limbs, featuring ulcers and scab formation, the patient was previously diagnosed with "psoriasis" before, however, clinicopathological correlation led to a diagnosis of granulomatous mycosis fungoides (GMF). The clinical and histological presentations of GMF are heterogeneous, and often mimic those of various inflammatory skin disorders. The patient's erythema and mass were biopsied separately, and the tumor cell characteristics included positivity for CD3+ and negativity for CD7-, CD4-, and CD8-. Immunohistochemical evaluations showed diffuse positivity for both T-cell lineage markers (CD2 and CD3), EBV Conclusion: This report explores the clinical and histological manifestations of GMF, features distinguishing GMF from other granulomatous diseases, such as IGD, and the prognostic significance of distinguishing GMF from classic mycosis fungoides. We aimed to raise awareness among physicians regarding this rare disease and emphasize the characteristic histological features of GMF that can be confused with other types of mycosis fungoides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.